HBK Investments’s Inspire Medical Systems INSP Stock Holding History

HBK Investments’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-67,100	Closed	-$3.81M	–	829
2019 Q1	$3.81M	Buy	67,100 +58,900	+718%	+$3.18M	0.04%	386
2018 Q4	$346K	Sell	8,200 -13,500	-62%	-$574K	﹤0.01%	998
2018 Q3	$913K	Buy	+21,700	New	+$1.02M	0.01%	755

Other funds holding INSP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

HBK Investments's INSP Position: Q2 2019 in Review

HBK Investments sold out of Inspire Medical Systems (INSP) in Q2 2019, closing a stake of 67,100 shares — an estimated $3.81M sold.

HBK Investments first reported a position in INSP in Q3 2018 and held it in 3 quarters. The position peaked at $3.81M in Q1 2019. 148 funds tracked by Wall St. Rank hold INSP as of Q2 2019.

HBK Investments reported no remaining Inspire Medical Systems position as of Q2 2019 after selling out during the quarter.
HBK Investments sold 67,100 Inspire Medical Systems shares in Q2 2019, an estimated $3.81M.
HBK Investments first reported a position in Inspire Medical Systems in Q3 2018 and held it in 3 quarters.
HBK Investments's Inspire Medical Systems position peaked at $3.81M in Q1 2019.
148 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.